Merck & Co Inc (NYSE:MRK)
| 92.44 Delayed Data As of Jul 01 |  +0.02 / +0.02%Today’s Change | 70.89 Today|||52-Week Range 95.72 | +20.62% Year-to-Date |
Latest MRK News | Press Releases
| Why Merck (MRK) Could Beat Earnings Estimates Again Jul 04 / Zacks.com - Paid Partner Content | 3 Stocks With Solid Records of Sales and Earnings Growth Jul 01 / GuruFocus News - Paid Partner Content |
| As Covid Cases Decline, is it Time to Drop Pfizer? Jul 04 / StockNews.com - Paid Partner Content | Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill Jul 01 / Zacks.com - Paid Partner Content |
| Q3 Likely to Remain Volatile: Top 5 Picks to Stay Safe Jul 04 / Zacks.com - Paid Partner Content | Has Merck & Co. (MRK) Outpaced Other Medical Stocks This Year? Jul 01 / Zacks.com - Paid Partner Content |
| Healthcare stocks may keep your portfolio from needing a checkup Jul 03 / CNN.com | The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J Jul 01 / Zacks.com - Paid Partner Content |
| Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA Jul 01 / Zacks.com - Paid Partner Content | Walgreens Boots (WBA) Q3 Earnings Top Estimates, Revenues Miss Jun 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 92.42 |
| Today’s open | 91.66 |
| Day’s range | 90.39 - 92.48 |
| Volume | 7,000 |
| Average volume (3 months) | 11,984,890 |
| Market cap | $233.7B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +84.65% |
| Earnings growth (this year) | +22.81% |
| Earnings growth (next 5 years) | +13.70% |
| Revenue growth (last year) | +1.86% |
| P/E ratio | 16.9 |
| Price/Sales | 3.98 |
| Price/Book | 6.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.12 | -0.18% |
| ABBVAbbVie | +0.64 | +0.42% |
| NVONovo Nordisk | -0.05 | -0.04% |
| NVSNovartis | -0.17 | -0.20% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | $1.68 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
